LEADER 04877nam 2201225z- 450 001 9910367747303321 005 20231214132924.0 010 $a3-03921-647-3 035 $a(CKB)4100000010106244 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/50545 035 $a(EXLCZ)994100000010106244 100 $a20202102d2019 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aThe Interplay of Microbiome and Immune Response in Health and Diseases 210 $cMDPI - Multidisciplinary Digital Publishing Institute$d2019 215 $a1 electronic resource (206 p.) 311 $a3-03921-646-5 330 $a[Increasing evidence suggests that microbiota and especially the gut microbiota (the microbes inhabiting the gut including bacteria, archaea, viruses, and fungi) plays a key role in human physiology and pathology. Recent findings indicate how dysbiosis?an imbalance in the composition and organization of microbial populations?could severely impact the development of different medical conditions (from metabolic to mood disorders), providing new insights into the comprehension of diverse diseases, such as IBD, obesity, asthma, autism, stroke, diabetes, and cancer. Given that microbial cells in the gut outnumber host cells, microbiota influences human physiology both functionally and structurally. Microbial metabolites bridge various?even distant?areas of the organism by way of the immune and hormone system. For instance, it is now clear that the mutual interaction between the gastrointestinal tract and the brain (gut?brain axis), often involves gut microbiota, indicating that the crosstalk between the organism and its microbial residents represents a fundamental aspect of both the establishment and maintenance of healthy conditions. Moreover, it is crucial to recognize that beyond the intestinal tract, microbiota populates other host organs and tissues (e.g., skin and oral mucosa). We have edited this eBook with the aim of publishing manuscripts focusing on the impact of microbiota in the development of different diseases and their associated treatments.] 610 $agastrointestinal diseases 610 $asterile inflammation 610 $aStaphylococcus spp. 610 $aetiopathogenesis 610 $acolitis 610 $aEscherichia coli 610 $abacteriophages 610 $aatopic dermatitis 610 $aintravenous immunoglobulin G 610 $aadaptive immunity 610 $a16S rRNA gene 610 $avaginal microbiota 610 $amodularity 610 $ainnate immunity 610 $agut-liver axis 610 $adisease activity 610 $aimmune system 610 $acytokines 610 $acommensals 610 $aStaphylococcus aureus 610 $adysbiosis 610 $afecal transplantation 610 $aTLR mimicry 610 $aetanercept 610 $adextran sulfate sodium 610 $aCAR T-cell 610 $a3-dihydroxy-4-methoxyBenzaldehyde 610 $achemo free treatment 610 $aStaphylococcus epidermis 610 $arheumatoid arthritis 610 $amicrobiome 610 $aco-occurrence network 610 $aimmune epigenetics 610 $a2 610 $aautoimmunity 610 $asuperoxide dismutase 610 $aprecision medicine 610 $ametabolism 610 $aadoptive cell transfer (ACT) 610 $agut barrier 610 $aantibiotics 610 $acheckpoint inhibitors 610 $aprobiotics 610 $amicrobiota 610 $aCandida albicans 610 $aEnterococcus faecalis 610 $achronic liver diseases 610 $aTCR 610 $aanaerobic bacteria 610 $aHSV2 610 $abacteriocins 610 $amethotrexate 610 $amicrobial interactions 610 $aT cells 610 $avirus 610 $amice 610 $alymphoid malignancies 610 $aHPV 610 $amacrophages 610 $aanti-TNF-? 610 $ainflammation 610 $achondroitin sulfate disaccharide 610 $aimmunotherapy 610 $agenomics 610 $aimmuno-oncology 610 $adiet 610 $aaerobic bacteria 610 $aimmunological niche 610 $amelanin 610 $ahealth 610 $achemokines 610 $agut microbiota 610 $acutaneous immunity 610 $aHIV 610 $aTIL 610 $acancer 610 $aglobal network 700 $aBarcelo?-Coblijn$b Gwendolyn$4auth$01324764 702 $aAmedei$b Amedeo$4auth 906 $aBOOK 912 $a9910367747303321 996 $aThe Interplay of Microbiome and Immune Response in Health and Diseases$93036268 997 $aUNINA